KalVista Pharmaceuticals, Inc.
Biotechnology · Healthcare
Chairman
2022-10-13–present
Chairman
KalVista Pharmaceuticals, Inc.
Equibles does not estimate personal net worth.
Brian J. G. Pereira is recorded as Chairman at KalVista Pharmaceuticals, Inc. since October 13, 2022. KalVista Pharmaceuticals, Inc. reported in an 8-K filed June 11, 2026 that Brian J. G. Pereira resigned as member of the Company's board of directors. KalVista Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company's board of directors and all committees thereof”
KalVista Pharmaceuticals, Inc.
Chairman
SEC 8-K
2022-10-13–present
KalVista Pharmaceuticals, Inc.
Board Member
Proxy statement
Start not stated–2026-06-11
KalVista Pharmaceuticals, Inc.
Biotechnology · Healthcare
Chairman
2022-10-13–present
KalVista Pharmaceuticals, Inc.